← Back to directory

Dominique Schols

Researcher Next ID · RN-035245

Researcher · Biochemistry, Genetics and Molecular Biology

Rega Institute for Medical Research

Leuven, Spain

Accepting doctoral researchersFunding unknown
Works count
883
Citation count
29,760
H-index
85
i10-index
418

Research interests

Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
HIV Research and Treatment
HIV/AIDS drug development and treatment
Immune Cell Function and Interaction
Chemokine receptors and signaling
Glycosylation and Glycoproteins Research

Publications

  • A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

    Nature · 2020 · https://doi.org/10.1038/s41586-020-3035-9

  • STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

    Nature Communications · 2020 · 10.1038/s41467-020-19684-y

  • Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity

    Molecules · 2018 · 10.3390/molecules23020286

  • The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model

    PLoS neglected tropical diseases · 2016 · 10.1371/journal.pntd.0004695

  • CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

    Proceedings of the National Academy of Sciences · 2010 · https://doi.org/10.1073/pnas.1012865107

  • CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization

    Current Pharmaceutical Design · 2010 · 10.2174/138161210794455003

  • Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

    JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 10.1097/01.qai.0000137371.80695.ef

  • Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4

    FEBS Letters · 2002 · 10.1016/s0014-5793(02)03143-5

  • AMD3100, a CxCR4 Antagonist, Attenuates Allergic Lung Inflammation and Airway Hyperreactivity

    American Journal Of Pathology · 2002 · 10.1016/s0002-9440(10)62562-x

  • CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity

    Nature Neuroscience · 2001 · https://doi.org/10.1038/89490

  • AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice

    The Journal of Immunology · 2001 · https://doi.org/10.4049/jimmunol.167.8.4686

  • Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity

    Journal of Virology · 2001 · https://doi.org/10.1128/jvi.75.21.10073-10089.2001

  • AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

    Nature Medicine · 1998 · https://doi.org/10.1038/nm0198-072

  • Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV

    Journal of Biological Chemistry · 1998 · https://doi.org/10.1074/jbc.273.13.7222

  • Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4

    Antiviral Research · 1997 · 10.1016/s0166-3542(97)00025-9

  • Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4

    The Journal of Experimental Medicine · 1997 · https://doi.org/10.1084/jem.186.8.1383

  • Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

    Proceedings of the National Academy of Sciences · 1993 · https://doi.org/10.1073/pnas.90.5.1711

  • Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine

    Antimicrobial Agents and Chemotherapy · 1993 · https://doi.org/10.1128/aac.37.2.332

  • Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.

    Proceedings of the National Academy of Sciences · 1992 · https://doi.org/10.1073/pnas.89.12.5286

  • The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro

    Antiviral Research · 1992 · https://doi.org/10.1016/0166-3542(92)90038-7

  • Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro

    Antimicrobial Agents and Chemotherapy · 1991 · https://doi.org/10.1128/aac.35.3.410

  • Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1

    Virology · 1990 · 10.1016/0042-6822(90)90440-3

  • Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

    Nature · 1990 · https://doi.org/10.1038/343470a0

  • Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative

    Biochemical and Biophysical Research Communications · 1989 · https://doi.org/10.1016/0006-291x(89)92756-3

  • Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

    Journal of Virological Methods · 1988 · https://doi.org/10.1016/0166-0934(88)90134-6

  • Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

    Antimicrobial Agents and Chemotherapy · 1988 · https://doi.org/10.1128/aac.32.7.1025

Current projects

    No projects listed.